miRNA-21 promotes cancer cell proliferation, survival, and migration by targeting phosphatase and tensin homolog (PTEN), the major negative regulator of the PI3K pathway, resulting in increased phosphoinositide 3-kinases (PI3K) activity (Yang et al. 2011). Here, PTEN is linked to cancer.